Automotive Smart Antenna Market

1
Human Microbiome Market Trends, Size, Share,
Demands, Overview, Growth, Revenue and Forecast
to 2030
sales_at_delvens.com www.delvens.com
2
Sternal Closure Systems Market Trends Forecast
Till 2030
Human Microbiome Market by Product (Prebiotics,
Probiotics, Food, Diagnostic Tests, Drugs),
Application (Therapeutic, Diagnostic), Disease
(Infectious, Metabolic/Endocrine), Research
Technology (Genomics, Proteomics, Metabolomics),
and region (North America, Europe, Asia-Pacific,
Middle East and Africa and South
America).
Request For Free Sample Report
https//www.delvens.com/get-free-sample/human-micr
obiome-market
sales_at_delvens.com
www.delvens.com
3
Market Overview
The human microbiota consists of the trillions of
symbiotic microbial cells harbored by each person
mainly bacteria in the gut. Microbes, including
bacteria, fungi, and viruses, are disease-causing
agent that accumulates over time, and the habitat
in the gut transforms their genetic activities
and metabolic processes, resulting in an abnormal
immune response against the substances and
tissues that are normally present in the human
body. Several microbiome projects have been
launched worldwide with the aim to understand the
roles played by these symbionts and their impact
on the health of human hosts. Human gut
microbiomes play a major role in improving the
efficacy of therapeutic compounds. Over the
years, studies have shown that the right
combination of microbes in the human body is
beneficial for treating different conditions.
This association between microbes and specific
disease states could generate new opportunities
for drug developers (or vaccine manufacturers).
With several small innovative players operating
in the market, there are various high-growth
opportunities for key stakeholders to buy out
companies so as to study microbiomes in the hope
of identifying new drugs and drug targets for
various indications, such as obesity, liver
disorders, diabetes, and metabolic
disorders. Purchase this Report
https//www.delvens.com/checkout/human-microbiome-
market
sales_at_delvens.com
www.delvens.com
4
Market Overview
The surging prevalence of respiratory diseases
all around the globe is one of the major factors
responsible for fostering growth in the market
value. Also, increasing focus on immunity
development is responsible for boosting the
market growth rate.  Additionally, the surge in
investment in biotechnology and biopharmaceutical
industries, the surge in the personal disposable
income level, an introduction of technologically
driven products in hospitals, increasing
investment in the development of advanced medical
products and devices, and a rise in the
popularity of minimally invasive surgeries,
positive affect the market growth rate. On the
other hand, the high initial cost associated with
the product is still persistent for many
organizations, these arise due to numerous
aspects including lack of funds, less floor
space, reliability, and infrastructure built, for
manual processes. Furthermore, these trucks are
operated in systematic spaces using the
predefined route and movement of products. This
results in lesser flexibility for industries that
require forklift trucks for multiple
purposes.
sales_at_delvens.com
www.delvens.com
5
Key Findings
The Human Microbiome Market is segmented into
product, disease, application, type, technology,
and region The application segment is
bifurcated into Therapeutics and Diagnostics. The
therapeutics segment is expected to dominate the
market during the forecast period. The increase
in funding for RD into microbiome-based
therapies worldwide is the major factor driving
the growth of this application segment. The
disease segment is further segmented into
Infectious Diseases, Endocrine and Metabolic
Disorders, Gastrointestinal Diseases, Cancer, and
Other Diseases. The infectious disease segment is
anticipated to hold the dominating position
during the forecast period.
sales_at_delvens.com
www.delvens.com
6
Key Findings
The technology segment is further segmented into
Genomics, Proteomics, and Metabolomics. The
genomics segment is expected to reach the highest
CAGR during the forecast period due to the
increasing number of projects funded by private
and government bodies is a key driver for the
genomics market. The market is also divided into
various regions such as North America, Europe,
Asia-Pacific, South America, and Middle East and
Africa. North America is estimated to account for
the largest market share during the forecast
period. Inquire Before Buying
https//www.delvens.com/Inquire-before-buying/huma
n-microbiome-market
sales_at_delvens.com
www.delvens.com
7
Competitive Landscape

• Rebiotix Inc.
• Yakult Honsha Co., Ltd.
• Synthetic Biologics Inc.
• DuPont
• MaaT Pharma
• Eligo Bioscience
• Merck Co. Inc
• AOBiome LLC
• Kaleido
• Seres Therapeutics

sales_at_delvens.com
www.delvens.com
8
Recent Developments
In 2022, OptiBiotix Health Plc. signed an
exclusive sales and distribution agreement with
Nahdi Medical Co. To help tackle the obesity
epidemic, the companys GoFigure and SlimBiome
Medical weight management products will be
available in the KSA from early 2022 through the
new agreement with Nahdi.  In September 2021,
PhenoBiome today launched a human gut microbiome
assay through Genetic Direction, which will
process the assays in its CLIA- and CAP-certified
laboratory.
sales_at_delvens.com
www.delvens.com
9
Contact Information
About Us Delvens is a strategic advisory and
consulting company headquartered in New Delhi,
India. The company holds expertise in providing
syndicated research reports, customized research
reports and consulting services. Delvens
qualitative and quantitative data is highly
utilized by each level from niche to major
markets, serving more than 1K prominent companies
by assuring to provide the information on
country, regional and global business
environment. We have a database for more than 45
industries in more than 115 major countries
globally. Contact Us 44-20-3290-6466 1
214-377-1144 sales_at_delvens.com
sales_at_delvens.com
www.delvens.com